Mary S. Rosendahl

Bolder Biotechnology, Inc.

$1,540,326

Attributed

$1,540,326

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $617.9K · FY2005–10

$1M$750K$500K$250K$0

'05

'06

'07

'08

'09

'10

Funding mix

By agency

NIH$1,540,326 · 8

By mechanism

R44$819,961 · 1

R43$720,365 · 7

Top collaborators

No co-investigators on record.

Most similar at Bolder Biotechnology, Inc.

Same institution · by research overlap

Daniel H Doherty$1,875,122
George Norbert Cox$22,120,941

Others in their field

Top investigators on “Biotechnology”

David Heimbrook · Leidos Biomedical Research, Inc.$140,255,767
Larry Arthur$82,860,406
Jaap Goudsmit · Beth Israel Deaconess Medical Center$53,211,858
Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$51,699,453
Richard A Gibbs · Baylor College Of Medicine$51,685,612
Garret A Fitzgerald · University Of Pennsylvania$50,415,853

Research focus

BiotechnologySite Directed MutagenesisPolyethylene GlycolsProtein EngineeringAntineoplasticsRecombinant ProteinsAngiogenesis InhibitorsProtein PurificationHigh Performance Liquid ChromatographyMolecular CloningLaboratory RatLaboratory MousePharmacokineticsCysteineDrug Design /Synthesis /ProductionNeoplasm /Cancer ChemotherapyDrug Screening /EvaluationBiotherapeutic AgentProtein Structure FunctionCell LineIon Exchange ChromatographyEnzyme Linked Immunosorbent AssayGrowth Factor ReceptorsTissue /Cell Culture